Adjuvant Systemic therapy for male breast carcinoma

Cancer

Volumn 104, Issue 11, 2005, Pages 2359-2364

  Giordano, Sharon H ^a   Perkins, George H ^a   Broglio, Kristine ^a   Garcia, Sherry G ^a   Middleton, Lavinia P ^a   Buzdar, Aman U ^a   Hortobagyi, Gabriel N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adjuvant systemic therapy; Male breast carcinoma

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GONADORELIN AGONIST; MEGESTROL ACETATE; METHOTREXATE; PREDNISONE; PROGESTERONE RECEPTOR; TAMOXIFEN; TAXANE DERIVATIVE; VINBLASTINE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS, MALE; CHEMOTHERAPY, ADJUVANT; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 28044460266     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21526     Document Type: Article

References (15)

1. Giordano SH, Cohen DS, Buzdar AU, et al. Breast carcinoma in men: a population-based study. Cancer. 2004;101:51-57.
2. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8-29.
3. Bagley CS, Wesley MN, Young RC, et al. Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol. 1987;10:55-60.
4. Goss PE, Reid C, Pintilie M, et al. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer. 1999;85: 629-639.
5. Ribeiro G, Swindell R, Harris M, Banerjee S, Cramer A. A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. Breast. 1996;5: 141-146.
6. Ribeiro G, Swindell R. Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer. 1992;65:252-254.
7. Donegan WL, Redlich PN, Lang PJ, et al. Carcinoma of the breast in males: a multiinstitutional survey. Cancer. 1998;83: 498-509.
8. Borgen PI, Wong GY, Vlamis V, et al. Current management of male breast cancer. A review of 104 cases. Ann Surg. 1992;215:451-457; discussion, 457-459.
9. Patel HZ, Buzdar AU, Hortobagyi GN. Role of adjuvant chemotherapy in male breast cancer. Cancer. 1989;64:1583-1585.
10. Izquierdo MA, Alonso C, De Andres L, et al. Male breast cancer. Report of a series of 50 cases. Acta Oncol. 1994;33: 767-771.
11. Yildirim E, Berberoglu U. Male breast cancer: a 22-year experience. Eur J Surg Oncol. 1998;24:548-552.
12. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet. 1998;352:930-942.
13. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer, an overview of the randomised trials. Lancet. 1998;351:1451-1467.
14. Scott-Conner CE, Jochimsen PR, Menck HR, et al. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery. 1999;126:775-780; discussion, 780-781.
15. Giordano SH, Buzdar AU, Smith TL, et al. Is breast cancer survival improving? Cancer. 2004;100:44-52.